Bernd Mühlenweg

Bernd Mühlenweg

Director/Board Member at SERNOVA BIOTHERAPEUTICS INC

Net worth: - $ as of 2026-08-30

54 year
Health Technology
Commercial Services
Consumer Services

Profile

Bernd Mühlenweg is the founder of Panoptes Pharma GmbH.
Current jobs include Independent Director at Sernova Biotherapeutics, Inc. since 2024, Chief Financial & Business Officer at Cellbox Solutions GmbH, Member of Pharma-Lizenz-Club Deutschland, and Member of Pharma Licensing Club France.
Former jobs include Senior Vice President-Global Business Development at Evotec SE from 2022 to 2024, Head-Business Development at Nanobiotix SA from 2011 to 2019, and Director-Business Development at Heidelberg Pharma AG.
Education includes a doctorate from Technische Universität München.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-21 0 ( -.--% ) - $ 2026-08-30

Bernd Mühlenweg active positions

CompaniesPositionStart
SERNOVA BIOTHERAPEUTICS INC Director/Board Member 2024-03-31
Pharma-Lizenz-Club Deutschland
Corporate Officer/Principal -
Pharma Licensing Club France
Corporate Officer/Principal -
Director of Finance/CFO -

Former positions of Bernd Mühlenweg

CompaniesPositionEnd
EVOTEC SE Corporate Officer/Principal 2024-05-31
NANOBIOTIX Corporate Officer/Principal 2019-06-29
Founder -
HEIDELBERG PHARMA AG Corporate Officer/Principal -
See the detail of Bernd Mühlenweg's experience

Training of Bernd Mühlenweg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

51

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Pharma-Lizenz-Club Deutschland

Pharma Licensing Club France

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Bernd Mühlenweg